NEUROINFLAMMATION IN CNS DISORDERS: PRIMING A TARGET FOR NEW THERAPIES



Similar documents
INNOVATION IN CNS DRUG DISCOVERY: FROM SMALL MOLECULES TO BIOLOGIC THERAPIES

PARKINSON S DISEASE MULTIPLE DOMAINS

INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA. SUMMER SCHOOL OF NEUROSCIENCE (7) Sesta scuola estiva di Neuroscienze (7)

INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA. SUMMER SCHOOL OF NEUROSCIENCE (7) Settima scuola estiva di Neuroscienze (7)

FIRST INTERNATIONAL PORTO PIRGOS CONFERENCE ON ADVANCES IN NEUROSCIENCE. Porto Pirgos Hotel ( Parghelia (VV), Calabria, Italy

Program. Society for Neuroscience Satellite Event. November 6-8 th 2013 San Diego, USA

International Symposium on: Pain and Cough

NEUROSCI 373/ PSY 279 Behavioral Neuroimmunology: Brain and Behavior in Health and Disease Fall 2012

How To Understand And Treat Pain In Neurobiological Conditions

Neurodegenerative diseases Includes multiple sclerosis, Parkinson s disease, post-polio syndrome, rheumatoid arthritis, lupus

Programme. Michele Grieco Dipartimento di Scienze Ambientali Seconda Università degli Studi di Napoli Naples, Italy

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press

NEUROSCIENCE. THE POWER OFxTM. Experts. Experience. Execution. Medpace Neuroscience Expertise. medpace.com

DRUG ADDICTION: from basic science to clinical management

placebo-controlledcontrolled double-blind, blind,

BSc in Medical Sciences with PHARMACOLOGY

Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers. Mont Ste. Odile, Alsace, France September 2008

29 January Rome, Italy

5 February Bari, Italy

Neurodegenerative diseases Includes multiple sclerosis, Parkinson s disease, postpolio syndrome, rheumatoid arthritis, lupus

Scientific Programme

GE Global Research. The Future of Brain Health

Neurodegenerative diseases Includes multiple sclerosis, Parkinson s disease, postpolio syndrome, rheumatoid arthritis, lupus

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine

SECOND CARDIOLOGY JOINT SEMINAR. Rome, April 12-13, Cardiovascular Center OLV Clinic Aalst Belgium. and

Fixture List 2018 FIFA World Cup Preliminary Competition

Programa Cooperación Farma-Biotech Neurociencias NT-KO-003

13 September London, UK

MS: from disease management to patient management

New Frontiers. in Glaucoma. Management. Rome, 7 February 2014 Donna Camilla Savelli Hotel

Summer School 2011 Berlin SFB Transregio 19

FOCUS ON BIOLOGICAL THERAPIES IN HEMATOLOGIC MALIGNANCIES

Project ideas of University of Udine for Horizon 2020 Health 2014/2015

NEW TRENDS IN PAIN RESEARCH From Basic Research to Clinical Translation

58th ANNUAL MEETING OF THE ITALIAN CANCER SOCIETY REVOLUTIONARY ROAD. VERONA SEPTEMBER Palazzo della GRAN GUARDIA. First Announcement

Cruise Line Agencies of Alaska. Cruise Ship Calendar for 2016 FOR PORT(S) = KTN AND SHIP(S) = ALL AND VOYAGES = ALL

American College of Allergy, Asthma & Clinical Immunology (ACAAI), USA International Center for Interdisciplinary Studies of Immunology Washington

Cruise Line Agencies of Alaska. Cruise Ship Calendar for 2016 FOR PORT(S) = KTN AND SHIP(S) = ALL AND VOYAGES = ALL

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data from three Phase III studies of the

2014 Neurologic Physical Therapy Professional Education Consortium Webinar Course Descriptions and Objectives

Calming microglia: a future method for treating multiple sclerosis Jarred Younger, PhD University of Alabama at Birmingham

Errata Sheet ATOM Catalog

FEDERAL PAIN PORTFOLIO PREVIEW

The Copernican Revolution in Ischemic Heart Diseases: the day after

XXIII AINI Congress Italian Association of Neuroimmunology Milan (Italy) August 22 nd, 2013

SCIENTIFIC PROGRAM ESSM School of Sexual Medicine October 2016, Budapest

Ariela Benigni. Biol.Sci.D., Ph.D. Curriculum Vitae

The Genetic Basis of Neurological Disorders

How To Find Out If The Gulf War And Health Effects Of Serving In The Gulf Wars Are Linked To Health Outcomes

Roche s marketing applications for review of OCREVUS (ocrelizumab) in two forms of multiple sclerosis accepted by EMA and FDA

Ageing Research in Trinity College

Complement in human disease, September 8th - 12th 2017

WHAT WILL YOU DISCOVER?

CONTRASTS IN PHARMACOLOGY 2.0

Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV

How To Learn More About Melanoma

Advances in Biology and Treatment of Malignant Brain Gliomas

Promises and challenges of developing new drugs in oncology

Progress in Motor Control X., Budapest, Hungary, July Symposium 1: Neurophysiological Mechanisms of Motor Control

Seminar/Talk Calendar

Increasing Innovation in R&D - Seizing early stage external growth opportunities

Novel therapeutic approaches in multiple sclerosis Neuroprotective and remyelinating agents, the future of clinical trials in MS?

GENENTECH S OCRELIZUMAB FIRST INVESTIGATIONAL MEDICINE TO SHOW EFFICACY IN PEOPLE WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS IN LARGE PHASE III STUDY

11 E.M.R.S.S. COURSE

INTERNATIONAL RETREAT OF PhD STUDENTS IN IMMUNOLOGY June 2015

16 TH EULAR POSTGRADUATE COURSE

HEALTH SCIENCES RESEARCH GROUPS AT THE UNIVERSITY OF ALICANTE. Field. Translational Research. Mortality Analysis. Public Health.

Promises and challenges of developing new drugs in oncology

Advanced Workshop For Central Bankers September 6-13, 2016

Autoimmunity and immunemediated. FOCiS. Lecture outline

STROKE CARE NOW NETWORK CONFERENCE MAY 22, 2014

Drugs, The Brain, and Behavior

CCM National Project PRECIOUS Care of patients with acquired severe brain injury in Italy. In collaboration with

Electrohypersensitivity and multiple chemical sensitivity: two clinicbiological. disorder?

Department of Neurology and Neurosurgery Clinical and Clinical Research Fellowship Application Form

Integrated Neuropsychological Assessment

CRS workshop 21 st -23 rd November 2013

Clinical and Therapeutic Cannabis Information. Written by Cannabis Training University (CTU) All rights reserved

Neurological Disorders Summit

Graduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine. Graduate Certificate. Metabolic & Nutritional Medicine

Eventuale spazio per nome struttura o altro. Pharmacy education. The Italian academic viewpoint

Clinical Departments in the Biological Sciences

ON CLINICAL PHARMACOLOGY OF ANTIRETROVIRALS 10 RESIDENTIAL COURSE January Starhotels Majestic. corso Vittorio Emanuele II 54 - TURIN

FORM ENTRY INSTRUCTIONS FOR THE RESEARCH SEMINARS AND EVENTS WEB PAGE

IADR/Unilever Hatton Awards Competition - Judges Room. IADR/Unilever Hatton Awards Competition SENIOR (Basic BH, Sala Ipe II

Cruise Line Agencies of Alaska. Cruise Ship Calendar for 2012 FOR PORT(S) = KTN AND SHIP(S) = ALL AND VOYAGES = ALL

Behavioral Neuroscience (BCPSY 1117, 1119) Course Syllabus

Serina Hoover, Psy.D., ABPP-RP, QME 7601 East Imperial Highway Downey, CA, 90242

Transcription:

INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA SUMMER SCHOOL OF NEUROSCIENCE (10) Decima scuola estiva di Neuroscienze (10) UNDER THE AUSPICES OF THE FEDERATION OF EUROPEAN PHARMACOLOGICAL SOCIETIES (EPHAR) THE ITALIAN SOCIETY OF PHARMACOLOGY (SIF) July 7-13, 2012 NEUROINFLAMMATION IN CNS DISORDERS: PRIMING A TARGET FOR NEW THERAPIES Catania Coro di Notte Ex Monastero dei Benedettini Piazza Dante, 32

Scientific Advisory Board Filippo Drago (Catania) (Chairman) Eugenio Aguglia (Catania) Renato Bernardini (Catania) Pier Luigi Canonico (Novara) Filippo Caraci (Catania) Donatella Marazziti (Pisa) Giancarlo Pepeu (Florence) Giorgio Racagni (Milan) Salvatore Salomone (Catania) Maria Angela Sortino (Catania) Organizing Secretariat Medea Communications s.r.l. Via Menza 19L - 95126 Catania Tel./Fax: +39 095 377412 e-mail: info@medeacom.com web: www.medeacom.com

Saturday July 7 th, 2012 10.00-14.15 Registration 14.15-14.30 Opening remarks Filippo Drago (Catania) 14.30-15.30 Opening lecture (introduced by Filippo Drago) Cytokines in CNS physiology and pathology Robert Dantzer (USA) 15.30-16.00 Welcome reception The interaction between CNS and immune system (1) Introduced and moderated by Giorgio Racagni (Italy) 16.00-17.00 Inflammatory signalling pathways in CNS disorders Cinzia Dello Russo (Italy) 17.00-18.00 Nerve-Driven Immunity: Neurotransmitters and Neuropeptides in the Immune System Mia Levite (Israel) 18.30-19.30 Immune proteins in synaptic plasticity Raffaella Molteni (Italy)

Sunday July 8 th, 2012 Stress, inflammation and neuroimmune interactions Introduced and moderated by Pierluigi Navarra (Italy) 10.00-11.00 The stressed CNS: role of glucocorticoids Ron De Kloet (The Netherlands) 11.00-12.00 Role of GITRL/GITR system as a modulator of immune response and inflammation: therapeutic perspectives Carlo Riccardi (Italy) The interaction between CNS and immune system (2) Introduced and moderated by Mia Levite (Israel) 16.00-17.00 Immune influence on adult neural stem cell regulation and function Maria Grazia Grilli (Italy) 17.00-18.00 Microglia and neuroprotection: from in vitro studies to therapeutic applications Barbara Monti (Italy) 18.30-19.30 Special Lecture: Immune activation in brain aging: too much or too little? Claudio Franceschi (Italy)

Monday July 9 th, 2012 Fibromyalgia and depressive disorders Introduced and moderated by Giovanna Maria Scoto (Italy) 10.00-11.00 Neuroendocrine immunology of fibromyalgia Riccardo Torta (Italy) 11.00-12.00 Fibromyalgia syndrome: from diagnosis to pharmacological treatment PierCarlo Sarzi-Puttini (Italy) 12.30-13.30 Neuroinflammation in the pathophysiology of depression: evidence from animal models Nicoletta Brunello (Italy) Multiple Sclerosis Introduced and moderated by Pier Luigi Canonico (Italy) 16.00-16.45 The role of regulatory T cells in multiple sclerosis Roland Liblau (France) 16.45-17.30 The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis Gianvito Martino (Italy) 17.30-18.15 Natural history of multiple sclerosis in the pediatric age: implications for outcome Martino Ruggieri (Italy) 18.15-1830 Discussion 18.30-19.30 Special Lecture: Treatment of multiple sclerosis: current concepts and future perspectives Bernard Hemmer (Germany)

Tuesday July 10 th, 2012 Stroke Introduced and moderated by Salvatore Salomone (Italy) 10.00-11.00 The role of immune system in the pathogenesis of ischemic stroke: identification of new pharmacological targets Alberto Chiarugi (Italy) 11.00-12.00 Neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective Mario Di Napoli (Italy) Alzheimer s disease Introduced and moderated by Giancarlo Pepeu (Italy) 16.00-17.00 Neuroinflammation: implications for the pathogenesis and molecular diagnosis of AD Claudio Cuello (Canada) 17.00-18.00 Passive immunotherapy in AD Beka Solomon (Israel) 18.30-19.30 Special Lecture: Active immunization strategies in AD: where do we stand? where should we go? Cynthia A. Lemere (USA)

Wednesday July 11t th, 2012 Neuroimmune interactions in neurodegenerative disorders Introduced and moderated by Maria Angela Sortino (Italy) 10.00-11.00 Neuroinflammation in amyotrophic lateral sclerosis: new targets for the treatment? Francesco Fornai (Italy) 11.00-12.00 mtor as a multifunctional therapeutic target in HIV infection Ferdinando Nicoletti (Italy) Parkinson s disease and other neurodegenerative disorders Introduced and moderated by Claudio Cuello (Canada) 16.00-17.00 Modeling neuroinflammatory pathogenesis of Parkinson's disease Fabio Blandini (Italy) 17.00-18.00 Cytokines and immunity in Parkinson's disease Mario Zappia (Italy) 18.30-19.30 Special lecture: Neuroinflammation in Parkinson s disease: a target for neuroprotection? Stephane Hunot (France)

Thursday July 12 th, 2012 Migraine Introduced and moderated by Stephane Hunot (France) 10.00-11.00 The role of neurogenic inflammation in the pathophysiology of migraine Salvatore Salomone (Italy) 11.00-12.00 Novel therapeutical targets in the treatment of migraine Pierangelo Geppetti (Italy) Pain Introduced and moderated by Pierangelo Geppetti (Italy) 16.00-17.00 Current challenges in glia-pain biology Marzia Malcangio (United Kingdom) 17.00-18.00 The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets Paola Sacerdote (Italy) 18.30-19.30 Special lecture: Modulation of peripheral sensory neurons by the immune system: implications for pain therapy Cristophe Stein (Germany)

Friday July 13 rd, 2012 Schizophrenia Introduced and moderated by Eugenio Aguglia (Italy) 10.00-11.00 Role of perinatal inflammation in the pathogenesis of schizophrenia Joram Feldon (Switzerland) 11.00-12.00 Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms Norbert Müller (Germany) 12.30-13,30 Sponsored lecture by Janssen-Cilag Neuroinflammation in CNS disorders Introduced and moderated by Donatella Marazziti (Italy) 16.00-17.00 Special lecture Neuroinflammation and omega-3 in synaptic circuitry: new targets for neuroprotection Nicolas G. Bazan (USA) 17.00-17.30 Discussion 17.30-18.30 Special Lecture The cytokine hypothesis of depression: new targets for adjunctive treatments in depression Michael Maes (Belgium) 18.30-18.45 Closing remarks Filippo Drago (Italy) 18.45-18.55 Questionnaire